Nature, Vol.584, No.7821, 333-334, 2020
CORONAVIRUS: WILL THE WORLD BENEFIT FROM ANTIBODY THERAPIES?
Monoclonal antibodies are complex and expensive to produce, meaning poor countries might be priced out. Monoclonal antibodies are complex and expensive to produce, meaning poor countries might be priced out.